Kuehn B. Reducing cervical cancer deaths. JAMA. 2019;322:198–198.

PubMed  Google Scholar 

Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.

Article  PubMed  Google Scholar 

Jin J. Screening for cervical cancer. JAMA. 2018;320:732–3.

Article  PubMed  Google Scholar 

Rahangdale L, Mungo C, O’Connor S, Chibwesha CJ, Brewer NT. Human papillomavirus vaccination and cervical cancer risk. BMJ. 2022;379: e070115.

Article  PubMed  Google Scholar 

Cohen PA, Jhingran A, Oaknin A, Denny L. Cervical cancer. The Lancet. 2019;393:169–82.

Article  Google Scholar 

Cremer M, Alfaro K, Masch R. Cervical cancer screening in low- and middle-income countries. JAMA. 2021;325:790–790.

Article  PubMed  Google Scholar 

Lucksom PG, Sherpa ML, Pradhan A, Lal S, Gupta C. Advances in HPV screening tests for cervical cancer-A review. J Obstet Gynaecol India. 2022;72:13–8.

Article  PubMed  Google Scholar 

Rathod S, Potdar J, Gupta A, Sethi N, Dande A. Empowering women’s Health: insights Into HPV vaccination and the prevention of invasive cervical cancer. Cureus. 2023;15: e49523.

PubMed  PubMed Central  Google Scholar 

Joseph A, Castedo-Delrieu M, Bloy N, Labaied N, Mondini M, Loi M, et al. Prognostic value of dendritic cells in locally advanced cervical cancer patients. J Clin Oncol. 2020;38:e18016–e18016.

Article  Google Scholar 

Lei J, Arroyo-Mühr LS, Lagheden C, Eklund C, Kleppe SN, Elfström M, et al. Human papillomavirus infection determines prognosis in cervical cancer. J Clin Oncol. 2022;40:1522–8.

Article  CAS  PubMed  Google Scholar 

Dueñas-González A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer. 2005;4:38.

Article  PubMed  PubMed Central  Google Scholar 

Brisson M, Drolet M. Global elimination of cervical cancer as a public health problem. Lancet Oncol. 2019;20:319–21.

Article  PubMed  Google Scholar 

Takekuma M, Matsuzaki S, Matsuo K. Utilization and outcome of systemic chemotherapy for high-risk early-stage cervical cancer. J Clin Oncol. 2021;39:e17521–e17521.

Article  Google Scholar 

Chaudary N, Hill RP, Kelley L, Milosevic MF. Effect of the oral CXCR4 inhibitor X4–136 on tumor control and side effects in cervical cancer treated with radiotherapy and concurrent chemotherapy. J Clin Oncol. 2020;38:e18010–e18010.

Article  Google Scholar 

Symonds R, Davidson S, Chan S, Reed N, McMahon T, Paul J. SCOTCERV: a phase II trial of docetaxel and gemcitabine as second-line chemotherapy in cervical cancer. J Clin Oncol. 2007;25:5548–5548.

Article  Google Scholar 

Li W, Chang L, Ju Y, Jiang M, Li L, Wang L, et al. Clinical research on radiotherapy at different time for unresectable cervical cancer. J Clin Oncol. 2013;31:e16516–e16516.

Article  Google Scholar 

Grau-Bejar JF, Garcia-Duran C, Garcia-Illescas D, Mirallas O, Oaknin A. Advances in immunotherapy for cervical cancer. Ther Adv Med Oncol. 2023;15:17588359231163836.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turinetto M, Valsecchi AA, Tuninetti V, Scotto G, Borella F, Valabrega G. Immunotherapy for cervical cancer: are we ready for prime time? Int J Mol Sci. 2022;23:3559.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao M, Monian P, Pan Q, Zhang W, Xiang J, Jiang X. Ferroptosis is an autophagic cell death process. Cell Res. 2016;26:1021–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Res. 2019;29:347–64.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang D, Chen X, Kroemer G. Cuproptosis: a copper-triggered modality of mitochondrial cell death. Cell Res. 2022;32:417–8.

Article  PubMed  PubMed Central  Google Scholar 

Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7:378.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li S-R, Bu L-L, Cai L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Transduct Target Ther. 2022;7:158.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cobine PA, Brady DC. Cuproptosis: cellular and molecular mechanisms underlying copper-induced cell death. Mol Cell. 2022;82:1786–7.

Article  CAS  PubMed  Google Scholar 

Wu M, Han Y, Gong X, Wan K, Liu Y, Zhou Y, et al. Novel insight of CircRNAs in cervical cancer: potential biomarkers and therapeutic target. Front Med. 2022;9:759928.

Article  Google Scholar 

Endale HT, Mariye YF, Negash HK, Hassen FS, Asrat WB, Mengstie TA, et al. MiRNA in cervical cancer: diagnosis to therapy: systematic review. Heliyon. 2024;10: e24398.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu J, Shang G. The roles of noncoding RNAs in the development of osteosarcoma stem cells and potential therapeutic targets. Front Cell Dev Biol. 2022;10:773038.

Article  PubMed  PubMed Central  Google Scholar 

Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430–447. https://doi.org/10.1038/s41580-022-00566-8.

Xie W, Chu M, Song G, Zuo Z, Han Z, Chen C, et al. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer. Semin Cancer Biol. 2022;83:303–18.

Article  CAS  PubMed  Google Scholar 

Chen X, Liu Y, Liu H, Wang ZW, Zhu X. Unraveling diverse roles of noncoding RNAs in various human papillomavirus negative cancers. Pharmacol Ther. 2022;238:108188.

Article  CAS  PubMed  Google Scholar 

Jiang W, Pan S, Chen X, Wang ZW, Zhu X. The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy. Mol Cancer. 2021;20:116.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang W, Xia J, Xie S, Zou R, Pan S, Wang ZW, et al. Long non-coding RNAs as a determinant of cancer drug resistance: towards the overcoming of chemoresistance via modulation of lncRNAs. Drug Resist Updat. 2020;50:100683.

Article  PubMed  Google Scholar 

Liao L-M, Zhang F-H, Yao G-J, Ai S-F, Zheng M, Huang L. Role of long noncoding RNA 799 in the metastasis of cervical cancer through upregulation of TBL1XR1 expression. Mol Ther—Nucl Acids. 2018;13:580–9.

Article  CAS  Google Scholar 

Meza-Sosa KF, Miao R, Navarro F, Zhang Z, Zhang Y, Hu JJ, et al. SPARCLE, a p53-induced lncRNA, controls apoptosis after genotoxic stress by promoting PARP-1 cleavage. Mol Cell. 2022;82:785-802.e710.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. lncRNA SNHG11 promotes gastric cancer progression by activating the Wnt/β-catenin pathway and oncogenic autophagy. Mol Ther. 2021;29:1258–78.

Article  CAS  PubMed  Google Scholar 

Huang J, Wang J, He H, Huang Z, Wu S, Chen C, et al. Close interactions between lncRNAs, lipid metabolism and ferroptosis in cancer. Int J Biol Sci. 2021;17:4493–513.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao J, Chen X, Liu X, Li R, Zhou X, Qu Y. Characterization of a ferroptosis and iron-metabolism related lncRNA signature in lung adenocarcinoma. Cancer Cell Int. 2021;21:340.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Gao X, Huang Y, Zhu X, Chen Y, Xue L, et al. Tumor microenvironment promotes lymphatic metastasis of cervical cancer: its mechanisms and clinical implications. Front Oncol. 2023;13:1114042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587–92.

Article  CAS  PubMed  Google Scholar 

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28:27–30.

Article  CAS  Pub